德信的投资者关系让股东了解公司进展和计划。
Non-Independent Executive Chairman
Non-Independent Non-Executive Director
Non-Independent Non-Executive Director
Senior Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
to find out more
of the company's
announcements.
For Investor Relations
related queries, please
contact the following:
• Robust sales : Revenue reaches record-high of RM1.9 billion (FY24 : RM1.8 billion)
• Higher dividend declared: Declares fourth interim dividend of 1.0 sen per share, bringing total full year dividend to 3.7 sen per share, equivalent to a dividend yield of approximately 7% (FY24 : 3.6 sen per share)
• Strong balance sheet: Cash and cash equivalents of RM672.2 million, more than four times total loans and borrowings of RM154.9 million
Cyberjaya, 29 April 2025 - DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, has announced its fourth quarter (“4QFY25”) and full-year financial results for the year ended 28 February 2025 (“FY25”) for the Company and its subsidiaries (“DXN Group” or the “Group”).
Read more~ Strengthening presence in fast-growing regions, with Latin America and Asia as key growth drivers ~
~ Declares second interim dividend of 0.8 sen ~
~ Declares first interim dividend of 0.9 sen ~